Skip to main content
Erschienen in: Updates in Surgery 2/2018

31.03.2018 | Original Article

Cutoff values of major surgical complications rates after gastrectomy

verfasst von: Gian Luca Baiocchi, Simone Giacopuzzi, Daniele Marrelli

Erschienen in: Updates in Surgery | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Gastric cancer is one of the most frequent cancers worldwide, and surgical resection remains the mainstay of the therapeutic pathway. Gastrectomy for cancer is still performed in many hospitals, and centralization remains limited to a small number of health systems. Morbidity and mortality after surgery for gastric cancer are surprisingly high. However, while mortality is obviously defined, major morbidity definitions still present some critical points. The aim of this study is to underline the need for universally accepted definitions of major complications and to describe the research agenda of a multicenter, European-based, prospective project launched by the European Chapter of the International Gastric Cancer Association (IGCA), with the goal of providing a list of complications related to gastrectomy for cancer with their definitions.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
3.
Zurück zum Zitat Pasquer A, Renaud F, Hec F, On behalf of the FREGAT Working Group—FRENCH et al (2016) Is centralization needed for esophageal and gastric cancer patients with low operative risk? A nationwide study. Ann Surg 264:823–830CrossRefPubMed Pasquer A, Renaud F, Hec F, On behalf of the FREGAT Working Group—FRENCH et al (2016) Is centralization needed for esophageal and gastric cancer patients with low operative risk? A nationwide study. Ann Surg 264:823–830CrossRefPubMed
5.
Zurück zum Zitat Messager M, de Steur WO, van Sandick JW et al (2016) Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: a survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre). Eur J Surg Oncol 42:116–122CrossRefPubMed Messager M, de Steur WO, van Sandick JW et al (2016) Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: a survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre). Eur J Surg Oncol 42:116–122CrossRefPubMed
6.
Zurück zum Zitat Cuschieri A, Fayers P, Fielding J et al (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Surgical Cooperative Group. Lancet 347:995–999CrossRefPubMed Cuschieri A, Fayers P, Fielding J et al (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Surgical Cooperative Group. Lancet 347:995–999CrossRefPubMed
7.
Zurück zum Zitat Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20CrossRefPubMed Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20CrossRefPubMed
8.
Zurück zum Zitat Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767–2773CrossRefPubMed Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767–2773CrossRefPubMed
9.
Zurück zum Zitat Roviello F, Pedrazzani C, Marrelli D et al (2010) Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol 36:439–446CrossRefPubMed Roviello F, Pedrazzani C, Marrelli D et al (2010) Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol 36:439–446CrossRefPubMed
10.
Zurück zum Zitat Bruce J, Russell EM, Mollison J et al (2001) The measurement and monitoring of surgical adverse events. Health Technol Assess 5:1–194CrossRefPubMed Bruce J, Russell EM, Mollison J et al (2001) The measurement and monitoring of surgical adverse events. Health Technol Assess 5:1–194CrossRefPubMed
11.
Zurück zum Zitat Koch CG, Li L, Hixson E et al (2012) What are the real rates of postoperative complications: elucidating inconsistencies between administrative and clinical data sources. J Am Coll Surg 214:798–805CrossRefPubMed Koch CG, Li L, Hixson E et al (2012) What are the real rates of postoperative complications: elucidating inconsistencies between administrative and clinical data sources. J Am Coll Surg 214:798–805CrossRefPubMed
12.
Zurück zum Zitat Baiocchi GL, Giacopuzzi S, Marrelli D, Bencivenga M, Morgagni P, Rosa F, Berselli M, Orsenigo E, Cananzi F, Tiberio G, Rausei S, Cozzaglio L, Degiuli M, Di Leo A, Fumagalli U, Portolani N, Rosati R, Roviello F, De Manzoni G, Italian Research Group for Gastric Cancer (GIRCG) (2017) Complications after gastrectomy for cancer: Italian perspective. Updates Surg. https://doi.org/10.1007/s13304-017-0478-0.pmid:28710718 CrossRefPubMed Baiocchi GL, Giacopuzzi S, Marrelli D, Bencivenga M, Morgagni P, Rosa F, Berselli M, Orsenigo E, Cananzi F, Tiberio G, Rausei S, Cozzaglio L, Degiuli M, Di Leo A, Fumagalli U, Portolani N, Rosati R, Roviello F, De Manzoni G, Italian Research Group for Gastric Cancer (GIRCG) (2017) Complications after gastrectomy for cancer: Italian perspective. Updates Surg. https://​doi.​org/​10.​1007/​s13304-017-0478-0.​pmid:​28710718 CrossRefPubMed
13.
Zurück zum Zitat Wu Z, Wang Q, Shi J et al (2017) Diagnostic criteria and risk assessment of complications after gastric cancer surgery in western countries. Zhonghua Wei Chang Wai Ke Za Zhi 20:135–139PubMed Wu Z, Wang Q, Shi J et al (2017) Diagnostic criteria and risk assessment of complications after gastric cancer surgery in western countries. Zhonghua Wei Chang Wai Ke Za Zhi 20:135–139PubMed
14.
Zurück zum Zitat Wu Z, Li Z, Ji J (2017) Recognition of postoperative complication after surgery for gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 20:121–124PubMed Wu Z, Li Z, Ji J (2017) Recognition of postoperative complication after surgery for gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 20:121–124PubMed
15.
Zurück zum Zitat Cancer Therapy Evaluation Program NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0; 2009 Cancer Therapy Evaluation Program NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0; 2009
16.
Zurück zum Zitat Clavien PA, Sanabria JR, Strasberg SM (1992) Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111:518–526PubMed Clavien PA, Sanabria JR, Strasberg SM (1992) Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111:518–526PubMed
17.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Slankamenac K, Graf R, Barkun J et al (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258:1–7CrossRefPubMed Slankamenac K, Graf R, Barkun J et al (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258:1–7CrossRefPubMed
19.
Zurück zum Zitat Clavien PA, Vetter D, Staiger R, Slankamenac K, Mehra T, Graf R, Puhan MA (2017) The comprehensive complication index (CCI®): added value and clinical perspectives 3 years down the line. Ann Surg 265:1045–1050CrossRefPubMed Clavien PA, Vetter D, Staiger R, Slankamenac K, Mehra T, Graf R, Puhan MA (2017) The comprehensive complication index (CCI®): added value and clinical perspectives 3 years down the line. Ann Surg 265:1045–1050CrossRefPubMed
20.
Zurück zum Zitat Low DE, Alderson D, Cecconello I et al (2015) International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg 262:286–294CrossRefPubMed Low DE, Alderson D, Cecconello I et al (2015) International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg 262:286–294CrossRefPubMed
21.
Zurück zum Zitat Katayama H, Kurokawa Y, Nakamura K et al (2016) Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today 46:668–685CrossRefPubMed Katayama H, Kurokawa Y, Nakamura K et al (2016) Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today 46:668–685CrossRefPubMed
Metadaten
Titel
Cutoff values of major surgical complications rates after gastrectomy
verfasst von
Gian Luca Baiocchi
Simone Giacopuzzi
Daniele Marrelli
Publikationsdatum
31.03.2018
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 2/2018
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-018-0530-8

Weitere Artikel der Ausgabe 2/2018

Updates in Surgery 2/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.